RU2001123035A - Химические соединения - Google Patents
Химические соединенияInfo
- Publication number
- RU2001123035A RU2001123035A RU2001123035/14A RU2001123035A RU2001123035A RU 2001123035 A RU2001123035 A RU 2001123035A RU 2001123035/14 A RU2001123035/14 A RU 2001123035/14A RU 2001123035 A RU2001123035 A RU 2001123035A RU 2001123035 A RU2001123035 A RU 2001123035A
- Authority
- RU
- Russia
- Prior art keywords
- glucopyranose
- benzylidene
- pharmaceutically acceptable
- viruses
- benzaldehyde derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
- C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
- C07H9/04—Cyclic acetals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/18—Acyclic radicals, substituted by carbocyclic rings
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Tropical Medicine & Parasitology (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Claims (6)
1. Применение 4,6-О-(бензилиден-d1)-D-глюкопиранозы, 4,6-O-бензилиден-L-глюкопиранозы и/или 4,6-О-(бензилиден-d1)-L-глюкопиранозы либо их фармацевтически приемлемой соли для производства фармацевтического препарата для профилактики и/или лечения рака печени, рака почек и рака поджелудочной железы.
2. Применение по п.1 для производства фармацевтического препарата для профилактического лечения раков, индуцируемых вирусами, такими как вирусы гепатита В и С, онкогенные вирусы папилломы и другие онкогенные вирусы.
3. Бензальдегидное производное, полезное в качестве терапевтического агента, представляющее собой 4,6-O-бензилиден-L-глюкопиранозу и/или 4,6-O-(бензилиден-d1)-L-глюкопиранозу либо их фармацевтически приемлемую соль.
4. Фармацевтическая композиция, содержащая бензальдегидное производное по любому из пп.1-3 и фармацевтически приемлемый носитель, разбавитель и/или эксципиент.
5. Способ производства фармацевтической композиции, при котором осуществляют стадию объединения бензальдегидного производного, как оно определено в любом из пп.1-4, с фармацевтически приемлемым носителем, разбавителем и/или эксципиентом.
6. Бензальдегидное производное, представляющее собой 4,6-O-бензилиден-L-глюкопиранозу, 4,6-O-(бензилиден-d2)-L-глюкопиранозу либо их фармацевтически приемлемую соль.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO990814A NO309305B1 (no) | 1999-02-19 | 1999-02-19 | Anvendelse av benzaldehydderivater ved fremstilling av farmasöytiske preparater for forebygging og/eller behandling av kreft, samt visse nye benzaldehydderivater |
NO19990814 | 1999-02-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2001123035A true RU2001123035A (ru) | 2004-03-20 |
Family
ID=19902986
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2001123035/14A RU2001123035A (ru) | 1999-02-19 | 2000-02-18 | Химические соединения |
RU2001123124/15A RU2001123124A (ru) | 1999-02-19 | 2000-02-18 | Химические соединения |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2001123124/15A RU2001123124A (ru) | 1999-02-19 | 2000-02-18 | Химические соединения |
Country Status (15)
Country | Link |
---|---|
EP (2) | EP1150690A1 (ru) |
JP (2) | JP2002537263A (ru) |
CN (2) | CN1347323A (ru) |
AU (2) | AU2834200A (ru) |
BR (2) | BR0008302A (ru) |
CA (2) | CA2362306A1 (ru) |
CZ (2) | CZ20012965A3 (ru) |
HU (2) | HUP0105281A2 (ru) |
IL (2) | IL144895A0 (ru) |
MX (2) | MXPA01008346A (ru) |
NO (1) | NO309305B1 (ru) |
PL (2) | PL350519A1 (ru) |
RU (2) | RU2001123035A (ru) |
SK (2) | SK11602001A3 (ru) |
WO (2) | WO2000048609A1 (ru) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002096921A1 (fr) * | 2001-05-30 | 2002-12-05 | Nisshin Seifun Group Inc. | Nouveau derive glucose induisant l'apoptose, procede de production et utilisation comme medicament |
DE10261807A1 (de) | 2002-12-19 | 2004-07-01 | Turicum Drug Development Ag | Deuterierte Catecholaminderivate sowie diese Verbindungen enthaltende Arzneimittel |
CN102134232B (zh) * | 2005-07-26 | 2012-11-21 | 奈科明有限责任公司 | 同位素取代的质子泵抑制剂 |
AR054583A1 (es) * | 2005-07-26 | 2007-06-27 | Altana Pharma Ag | Pantoprazol isotopicamente sustituido |
WO2007041630A1 (en) * | 2005-10-06 | 2007-04-12 | Auspex Pharmaceuticals, Inc. | Deuterated inhibitors of gastric h+, k+-atpase with enhanced therapeutic properties |
CN101157711B (zh) * | 2007-09-28 | 2010-12-08 | 西安交通大学 | 一种具有抗肿瘤活性的化合物及其用途 |
MX339451B (es) * | 2008-04-03 | 2016-05-27 | Cognate 3 Llc | Composiciones y metodos para inmunoterapia. |
CN101735284B (zh) * | 2008-11-24 | 2012-05-23 | 上海医药工业研究院 | 一种4,6-o-苄叉-d-吡喃葡萄糖的制备方法 |
CN114366741A (zh) | 2013-12-03 | 2022-04-19 | 细胞内治疗公司 | 新方法 |
US10077267B2 (en) | 2014-04-04 | 2018-09-18 | Intra-Cellular Therapies, Inc. | Organic compounds |
JP6898072B2 (ja) * | 2015-08-27 | 2021-07-07 | 秀行 佐谷 | 14−3−3タンパク質活性調節剤 |
ES2879888T3 (es) | 2016-03-25 | 2021-11-23 | Intra Cellular Therapies Inc | Compuestos orgánicos y su uso en el tratamiento o prevención de trastornos del sistema nervioso central |
JP7013454B2 (ja) | 2016-10-12 | 2022-02-15 | イントラ-セルラー・セラピーズ・インコーポレイテッド | アモルファス固体分散体 |
BR112019019875A2 (pt) | 2017-03-24 | 2020-04-22 | Intra Cellular Therapies Inc | novas composições e métodos |
BR112021003655A2 (pt) | 2018-08-31 | 2021-05-18 | Intra-Cellular Therapies, Inc. | métodos novos |
US10695345B2 (en) | 2018-08-31 | 2020-06-30 | Intra-Cellular Therapies, Inc. | Pharmaceutical capsule compositions comprising lumateperone mono-tosylate |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB811510A (en) * | 1954-12-20 | 1959-04-08 | Gyogyszeripari Ki | New nitrogen-containing derivatives of polyhydroxy compounds and process for the preparation thereof |
JPS6112623A (ja) * | 1984-06-28 | 1986-01-21 | Kaken Pharmaceut Co Ltd | エンケフアリナ−ゼ阻害剤 |
JPS6256423A (ja) * | 1985-09-06 | 1987-03-12 | Kaken Pharmaceut Co Ltd | 悪液質治療改善剤 |
GB8705780D0 (en) * | 1987-03-11 | 1987-04-15 | Norsk Hydro As | Anticancer compounds |
JPH07145191A (ja) * | 1993-11-24 | 1995-06-06 | Japan Tobacco Inc | ガラクトシルホスフォネート誘導体 |
-
1999
- 1999-02-19 NO NO990814A patent/NO309305B1/no not_active IP Right Cessation
-
2000
- 2000-02-18 RU RU2001123035/14A patent/RU2001123035A/ru unknown
- 2000-02-18 AU AU28342/00A patent/AU2834200A/en not_active Abandoned
- 2000-02-18 JP JP2000599400A patent/JP2002537263A/ja active Pending
- 2000-02-18 CA CA002362306A patent/CA2362306A1/en not_active Abandoned
- 2000-02-18 CN CN00806488A patent/CN1347323A/zh active Pending
- 2000-02-18 EP EP00906782A patent/EP1150690A1/en not_active Withdrawn
- 2000-02-18 CN CN00806338A patent/CN1347322A/zh active Pending
- 2000-02-18 PL PL00350519A patent/PL350519A1/xx not_active Application Discontinuation
- 2000-02-18 JP JP2000599401A patent/JP2002537264A/ja active Pending
- 2000-02-18 MX MXPA01008346A patent/MXPA01008346A/es not_active Application Discontinuation
- 2000-02-18 CZ CZ20012965A patent/CZ20012965A3/cs unknown
- 2000-02-18 RU RU2001123124/15A patent/RU2001123124A/ru unknown
- 2000-02-18 IL IL14489500A patent/IL144895A0/xx unknown
- 2000-02-18 PL PL00350520A patent/PL350520A1/xx not_active Application Discontinuation
- 2000-02-18 BR BR0008302-0A patent/BR0008302A/pt not_active Application Discontinuation
- 2000-02-18 MX MXPA01008347A patent/MXPA01008347A/es not_active Application Discontinuation
- 2000-02-18 HU HU0105281A patent/HUP0105281A2/hu unknown
- 2000-02-18 WO PCT/NO2000/000059 patent/WO2000048609A1/en not_active Application Discontinuation
- 2000-02-18 WO PCT/NO2000/000060 patent/WO2000048610A1/en not_active Application Discontinuation
- 2000-02-18 HU HU0105280A patent/HUP0105280A2/hu unknown
- 2000-02-18 AU AU28341/00A patent/AU2834100A/en not_active Abandoned
- 2000-02-18 BR BR0008297-0A patent/BR0008297A/pt not_active Application Discontinuation
- 2000-02-18 CZ CZ20012966A patent/CZ20012966A3/cs unknown
- 2000-02-18 SK SK1160-2001A patent/SK11602001A3/sk unknown
- 2000-02-18 IL IL14489600A patent/IL144896A0/xx unknown
- 2000-02-18 EP EP00906781A patent/EP1150689A1/en not_active Withdrawn
- 2000-02-18 CA CA002363670A patent/CA2363670A1/en not_active Abandoned
- 2000-02-18 SK SK1161-2001A patent/SK11612001A3/sk unknown
Also Published As
Publication number | Publication date |
---|---|
HUP0105280A2 (hu) | 2002-04-29 |
JP2002537263A (ja) | 2002-11-05 |
NO990814D0 (no) | 1999-02-19 |
NO309305B1 (no) | 2001-01-15 |
IL144895A0 (en) | 2002-06-30 |
MXPA01008346A (es) | 2003-06-06 |
RU2001123124A (ru) | 2004-02-20 |
CA2363670A1 (en) | 2000-08-24 |
CN1347323A (zh) | 2002-05-01 |
MXPA01008347A (es) | 2004-03-10 |
PL350519A1 (en) | 2002-12-16 |
IL144896A0 (en) | 2002-06-30 |
WO2000048610A1 (en) | 2000-08-24 |
CN1347322A (zh) | 2002-05-01 |
CA2362306A1 (en) | 2000-08-24 |
AU2834200A (en) | 2000-09-04 |
WO2000048609A1 (en) | 2000-08-24 |
HUP0105281A2 (hu) | 2002-05-29 |
AU2834100A (en) | 2000-09-04 |
NO990814L (no) | 2000-08-21 |
CZ20012965A3 (cs) | 2002-03-13 |
JP2002537264A (ja) | 2002-11-05 |
PL350520A1 (en) | 2002-12-16 |
BR0008302A (pt) | 2002-08-27 |
SK11612001A3 (sk) | 2002-04-04 |
CZ20012966A3 (cs) | 2002-03-13 |
SK11602001A3 (sk) | 2002-02-05 |
EP1150690A1 (en) | 2001-11-07 |
BR0008297A (pt) | 2002-05-28 |
EP1150689A1 (en) | 2001-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2001123035A (ru) | Химические соединения | |
WO2002016357A3 (en) | Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands) | |
WO2002016358A3 (en) | Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands) | |
GB0119249D0 (en) | Organic compounds | |
NO20041631L (no) | Piperazinderivater med CCR1 reseptor antagonist | |
PL366726A1 (en) | 4'-substituted nucleosides for the treatment of diseases mediated by the hepatitis c virus | |
CA2413163A1 (en) | 3'-prodrugs of 2'-deoxy-.beta.-l-nucleosides | |
HUP0401434A3 (en) | Photosensitizing agent containing sulphonated meso-tetra-phenylporphyrin, process for its preparation and pharmaceutical compositions containing thereof | |
NO20041994L (no) | Nye beta-fenyl-alfa-oksysubstituerte propion derivater: Fremgangsmate for deres fremstilling og deres anvendelse ved fremstilling av farmasoytisk riktige forbindelser | |
JP2006514012A5 (ru) | ||
GB2355932B (en) | A pharmaceutical formulation suitable for the treatment of hepatitis B, hepatitis C and other viral infections of the liver and a process for its preparation | |
PT992509E (pt) | Novos derivados macrolidos | |
WO2005007601A3 (en) | Substituted arylthiourea derivatives useful as inhibitors of viral replication | |
AU2002341241A1 (en) | Process for the preparation of fast dissolving dosage form | |
RU2003118411A (ru) | Кристаллические производные 1-метилкарбапенема | |
EE200000472A (et) | Kasvajavastased toimeained | |
IL150817A0 (en) | Pyrrole-type compounds, compositions, and methods for treating cancer or viral diseases | |
GEP20074058B (en) | 4-(7-halo-2-quino(xa) linyloxy-phenoxy-propionic acid derivatives as antineoplastic agents | |
RU2003118500A (ru) | Средство для ингибирования репродукции оболоченных вирусов, способ его получения, фармацевтическая композиция и способ ингибирования вирусных инфекций | |
WO2004029064A8 (en) | (+)-trans-isomers of (1-phosphonomethoxy-2-alkylcyclopropyl) methyl nucleoside derivatives, process for the preparation of stereoisomers thereof, and use of antiviral agents thereof | |
WO2003047505A3 (en) | Topoisomerase poison agents | |
DK0380038T3 (da) | 3-Phenyl-5,6-dihydrobenz(c)acridin-7-carboxylsyrer og beslægtede forbindelser som kemoterapeutiske midler mod cancer | |
CA2380852A1 (en) | Tricyclic compounds having spiro union | |
AP9801235A0 (en) | Erythromycin derivatives. | |
HUP0401617A3 (en) | Process for the preparation of (r)- or (s)-aminocarnitine inner salt, the salts and derivatives thereof |